Noom's Microdose GLP-1Rx Program directly addresses each of these three barriers, to help meaningfully bend the obesity curve
The plan also includes a free app for ongoing support and messaging with a healthcare professional
They do not contain GLP-1 receptor agonists and will not produce the same effects as Ozempic or Wegovy (6)
Those who met the following criteria were excluded from the trial: estimated glomerular filtration rate (eGFR) of less than 30 mL/min/1.73 m 2 , age of 30 years or younger, A1C less than 5.5% or greater than 11%, percutaneous coronary intervention within 15 days, coronary artery bypass graft for the qualifying event, or planned coronary revascularization procedure within 90 days after screening
In the SURMOUNT-5 trial, which directly compared the two medications, Mounjaro 15 mg produced 20.2% weight loss, while Wegovy 2.4 mg produced 13.7% over 72 weeks
Well guess what, tl;dr is here to give you the rundown on what you need to know to join in on that super nerdy pharmacy conversation happening at the bar after work (cmon, you know you all do it)